Additional file 1: of Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy

Yu Kanemaru (Creator)
Manabu Natsumeda (Creator)
Masayasu Okada (Creator)
Rie Saito (Creator)
Daiki Kobayashi (Creator)
Takeyoshi Eda (Contributor)
Jun Watanabe (Creator)
Shoji Saito (Creator)
Yoshihiro Tsukamoto (Creator)
Makoto Oishi (Creator)
Hirotake Saito (Creator)
Masayuki Nagahashi (Creator)
Takahiro Sasaki (Creator)
Rintaro Hashizume (Contributor)
Hidefumi Aoyama (Creator)
Toshifumi Wakai (Creator)
Akiyoshi Kakita (Creator)
Yukihiko Fujii (Creator)

Dataset

Description

Table S1. A table listing the 435 genes in the comprehensive genomic sequencing panel. (TIF 7228 kb)

Date made available	2019
Publisher	figshare

DOI
10.6084/m9.figshare.9109313.v1

Access Dataset

CC BY + CC0

1 Article

Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy
Kanemaru, Y., Natsumeda, M., Okada, M., Saito, R., Kobayashi, D., Eda, T., Watanabe, J., Saito, S., Tsukamoto, Y., Oishi, M., Saito, H., Nagahashi, M., Sasaki, T., Hashizume, R., Aoyama, H., Wakai, T., Kakita, A. & Fujii, Y., Jul 25 2019, In: Acta Neuropathologica Communications. 7, 1, p. 119 1 p.
Research output: Contribution to journal › Article › peer-review

Open Access
31 Scopus citations

Cite this

Kanemaru, Y. (Creator), Natsumeda, M. (Creator), Okada, M. (Creator), Saito, R. (Creator), Kobayashi, D. (Creator), Eda, T. (Contributor), Watanabe, J. (Creator), Saito, S. (Creator), Tsukamoto, Y. (Creator), Oishi, M. (Creator), Saito, H. (Creator), Nagahashi, M. (Creator), Sasaki, T. (Creator), Hashizume, R. (Contributor), Aoyama, H. (Creator), Wakai, T. (Creator), Kakita, A. (Creator), Fujii, Y. (Creator) (2019). Additional file 1: of Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy. figshare. 10.6084/m9.figshare.9109313.v1

Additional file 1: of Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy

Description

DOI

Access Dataset

Research output

Dramatic response of BRAF V600E-mutant epithelioid glioblastoma to combination therapy with BRAF and MEK inhibitor: establishment and xenograft of a cell line to predict clinical efficacy

Cite this